BioregulatorResearch
Sigumir
Also known as: Cartilage & Bone Extract Bioregulator
A Cytomax bioregulator for total skeletal and articular regeneration from cartilage and bone matrix extracts.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
Per bioregulator protocol
Administration
Oral capsule
Mechanism of Action
Epigenetic restoration of musculoskeletal gene expression for joint capsule rebuilding and bone density maintenance.
Key Research Areas
bioregulatorbonecartilageosteoporosis
Frequently Asked Questions
What is Sigumir?▾
A Cytomax bioregulator for total skeletal and articular regeneration from cartilage and bone matrix extracts.
How does Sigumir work?▾
Epigenetic restoration of musculoskeletal gene expression for joint capsule rebuilding and bone density maintenance.
What is the recommended dosage for Sigumir?▾
The typical research dosage is Per bioregulator protocol, administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Sigumir?▾
The half-life of Sigumir is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Sigumir FDA approved?▾
Sigumir is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Sigumir is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.